Caricamento...

Potential biomarkers to follow the progression and treatment response of Huntington’s disease

Huntington’s disease (HD) is a rare genetic disease caused by expanded polyglutamine repeats in the huntingtin protein resulting in selective neuronal loss. Although genetic testing readily identifies those who will be affected, current pharmacological treatments do not prevent or slow down disease...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Exp Med
Autori principali: Disatnik, Marie-Hélène, Joshi, Amit U., Saw, Nay L., Shamloo, Mehrdad, Leavitt, Blair R., Qi, Xin, Mochly-Rosen, Daria
Natura: Artigo
Lingua:Inglês
Pubblicazione: The Rockefeller University Press 2016
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5110026/
https://ncbi.nlm.nih.gov/pubmed/27821553
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1084/jem.20160776
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !